The U.S. House Energy and Commerce Health Subcommittee yesterday approved twelve bills to address the opioid crisis and other substance abuse disorders. The full committee is expected to consider the bills as early as next week, with possible votes on the House floor in early May. According to a American Hospital Association bulletin: the bills would establish an inter-agency task force to review and update best practices for pain management and prescribing (H.R. 4641); create a grant program for co-prescribing opioid reversal drugs to high-risk patients (H.R. 3680); improve access to information on opioid risks and alternative treatments for youth with sports-related injuries (H.R. 4969); authorize state grants to develop naloxone standing orders (H.R. 4586); among other mandates. The subcommittee also approved draft legislation to expand access to medication-assisted treatment and require the GAO to report to Congress on substance abuse treatment availability.
Read further details about these bills from the Subcommittee here.